Pharma Business International | The voice of the Pharma industry

Finance

Glox Therapeutics awarded £1m PACE grant to accelerate development of precision antibiotics against antimicrobial-resistant pathogens

20th November 2024

Glox Therapeutics, a company pioneering the development of precision antibiotic therapies based on naturally occurring bacteriocins, has secured £1 million in grant funding from PACE (Pathways to Antimicrobial Clinical...

APPROVALS

UCB receives U.S. FDA approval for BIMZELX as first IL-17A and IL-17F inhibitor for adults with moderate to severe hidradenitis suppurativa

Finance

Cytomos secures £5m to scale up production of cell analysis technology

View the Online Magazine

Latest Issue

Magazine Archive

Launches

Merck opens new €290m biosafety testing facility

Merck has opened its new €290 million biosafety testing facility in Rockville, Maryland, USA. Biosafety testing and analytical development are fundamental components of drug...

Beckman Coulter and Scopio Labs add world’s first digital bone marrow imaging and analysis to long-term partnership

Beckman Coulter, a clinical diagnostics leader, and Scopio Labs, a medtech company that develops digital cell morphology workflow solutions, jointly announced the expansion of...

DOL Finder platform launch enables users to identify and monitor most influential digital healthcare professionals active in key disease spaces

A UK and US based digital insights consultancy has launched a new platform, DOL Finder, that enables users to identify the most influential healthcare...

Suppliers Guide

Check out our Suppliers Guide or contact our team and get your company listed

Keep up with what's happening in the industry and subscribe to our weekly newsletter

Events

Get your event seen by potential candidates on the world's leading industry site.

Supply Chain

Camida wins Pharma Supplier of the Year!

The much-coveted title, Pharma Supplier of the Year, was bestowed upon Camida at the 2024 Pharma Industry Awards. (Wednesday, 30 October / Dublin, Ireland) Camida...

AscellaHealth acquires CHAPPER healthcare

AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, has acquired CHAPPER healthcare, a global specialty pharmaceutical wholesaler, distributor and...

ProductLife Group strengthens global drug development capabilities with acquisition of IntiQuan

ProductLife Group (PLG), a regulatory, scientific, compliance, and digital transformation consulting services firm for the life sciences industry, has acquired IntiQuan, a Swiss boutique...

Astoriom expands biorepository services with new acquisition

Astoriom, a leader in the R&D Sample Stability and Biorepository Storage industry, has acquired the biorepository business of Flagship Biosciences as it strategically expands within the...

Approvals

UCB receives U.S. FDA approval for BIMZELX as first IL-17A and IL-17F inhibitor for adults with moderate to severe hidradenitis suppurativa

The U.S. Food and Drug Administration (FDA) has approved UCB's BIMZELX (bimekizumab-bkzx) for the treatment of adults with moderate to severe hidradenitis suppurativa (HS)....

FDA approves first gene therapy for aromatic L-amino acid decarboxylase deficiency

The U.S. Food and Drug Administration has approved Kebilidi (eladocagene exuparvovec-tneq), an adeno-associated virus vector-based gene therapy indicated for the treatment of adult and...

Fasenra approved in the EU for eosinophilic granulomatosis with polyangiitis

Health Canada approves oral targeted treatment for brain cancer

Astellas’ VYLOYTM approved by U.S. FDA for advanced gastric and GEJ cancer

DARZALEX (daratumumab)-SC based quadruplet regimen approved by the European Commission for patients with newly diagnosed multiple myeloma who are transplant-eligible

Manufacturiung

MANUFACTURING

Process filter maker creates new global pharma and healthcare role

A UK process filter manufacturer has appointed a top sales and procurement expert with extensive experience of biotech engineering to lead its strategy for...

GSK to make up to $800m manufacturing investment in Pennsylvania

FibroBiologics and Charles River collaborate to manufacture fibroblast cell-based therapies for chronic diseases

£4.5m project launched to tackle acute skills shortage in UK medicines manufacturing

New $4.5bn Lilly site to drive innovation in drug production and make medicines for clinical trials

Ferring Pharmaceuticals bolsters global gene therapy supply chain with European manufacturing facility

Finance

Glox Therapeutics awarded £1m PACE grant to accelerate development of precision antibiotics against antimicrobial-resistant pathogens

Cytomos secures £5m to scale up production of cell analysis technology

AbbVie to acquire Aliada Therapeutics

Lundbeck to acquire Longboard Pharmaceuticals

Research & Development
Latest

R&D

GSK to acquire CMG1A46 from Chimagen Biosciences, expanding immunology pipeline

31st October 2024

GSK and Chimagen Biosciences have announced an agreement for GSK to acquire CMG1A46, a clinical-stage dual CD19 and CD20-targeted T cell-engager (TCE), from Chimagen...

R&D

Dyno Therapeutics forms partnership with Roche to advance AAV gene therapy vectors for neurological diseases

30th October 2024

Dyno Therapeutics, a genetic technologies company applying artificial intelligence (AI) to enable in vivo gene delivery, has announced its second research collaboration with Roche...

R&D

ViaNautis Bio signs agreement with Lilly to develop novel products delivering genetic medicines

29th October 2024

ViaNautis Bio, a biotechnology company at the forefront of delivering targeted genetic nanomedicines, has announced a collaboration with Eli Lilly and Company. Under the terms...

R&D

AbbVie and Gedeon Richter to discover and develop novel targets for neuropsychiatric conditions

25th October 2024

AbbVie and Gedeon Richter have announced a new discovery, co-development and license agreement to advance novel targets for the potential treatment of neuropsychiatric conditions. This...

R&D

Cancer Research UK and KisoJi Biotechnology collaborate to advance the first naked antibody against TROP2 into the clinic

24th October 2024

Cancer Research UK, one of the world’s largest funders of cancer research, and KisoJi Biotechnology, a company focussed on the discovery and development of...

View the Online Magazine

Launches

Suppliers Guide

Subscribe

Events

Supply Chain

Approvals

Manufacturiung

Finance

Research & DevelopmentLatest

Appointments

About Us

Popular Category

Editor Picks

Research & Development
Latest